Authors:
Broughton, HB
Gordaliza, M
Castro, MA
del Corral, JMM
San Feliciano, A
Citation: Hb. Broughton et al., Modified CoMFA methods for the analysis of antineoplastic effects of lignan analogues, J MOL ST-TH, 504, 2000, pp. 287-294
Authors:
Low, CMR
Black, JW
Broughton, HB
Buck, IM
Davies, JMR
Dunstone, DJ
Hull, RAD
Kalindjian, SB
McDonald, IM
Pether, MJ
Shankley, NP
Steel, KIM
Citation: Cmr. Low et al., Development of peptide 3D structure mimetics: Rational design of novel peptoid cholecystokinin receptor antagonists, J MED CHEM, 43(19), 2000, pp. 3505-3517
Authors:
Russell, MGN
Matassa, VG
Pengilley, RR
van Niel, MB
Sohal, B
Watt, AP
Hitzel, L
Beer, MS
Stanton, JA
Broughton, HB
Castro, JL
Citation: Mgn. Russell et al., 3-[3-(Piperidin-1-yl)propyl] indoles as highly selective h5-HT1D receptor agonists, J MED CHEM, 42(24), 1999, pp. 4981-5001
Authors:
van Niel, MB
Collins, I
Beer, MS
Broughton, HB
Cheng, SKF
Goodacre, SC
Heald, A
Locker, KL
MacLeod, AM
Morrison, D
Moyes, CR
O'Connor, D
Pike, A
Rowley, M
Russell, MGN
Moyes, CR
O'Connor, D
Pike, A
Rowley, M
Russell, MGN
Sohal, B
Stanton, JA
Thomas, S
Verrier, H
Watt, AP
Castro, JL
Citation: Mb. Van Niel et al., Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles, J MED CHEM, 42(12), 1999, pp. 2087-2104